LIFE - aTyr Pharma - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $10.47. This is a potential upside of $8.49 (428.79%) from yesterday's end of day stock price of $1.98.

aTyr Pharma's activity chart (see below) currently has 23 price targets and 21 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 18.75% with an average time for these price targets to be met of 10.88 days.

Most recent stock forecast was given by EDWARD TENTHOFF from PIPER SANDLER on 19-Jul-2023. First documented stock forecast 10-Apr-2016.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$3

$1.02 (51.52%)

$9

2 years 2 months 21 days ago
(19-Jul-2023)

0/3 (0%)

$0.97 (47.78%)

Buy

$19

$17.42 (1102.53%)

2 years 5 months 1 days ago
(10-May-2023)

0/1 (0%)

$16.74 (740.71%)

Buy

$22

2 years 7 months 9 days ago
(01-Mar-2023)

0/1 (0%)

$12.5 (131.58%)

Buy

3 years 2 months 20 days ago
(20-Jul-2022)

0/2 (0%)

$8.85 (96.72%)

Buy

3 years 6 months 6 days ago
(04-Apr-2022)

0/2 (0%)

$11 (122.22%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is LIFE (aTyr Pharma) average time for price targets to be met?

On average it took 10.88 days on average for the stock forecasts to be realized with a an average price target met ratio 18.75

Which analyst has the current highest performing score on LIFE (aTyr Pharma) with a proven track record?

HARTAJ SINGH

Which analyst has the current lower performing score on LIFE (aTyr Pharma) with a proven track record?

MATTHEW LUCHINI

Which analyst has the most public recommendations on LIFE (aTyr Pharma)?

Hartaj Singh works at OPPENHEIMER and has 6 price targets and 8 ratings on LIFE

Which analyst is the currently most bullish on LIFE (aTyr Pharma)?

Gregory Renza with highest potential upside - $17.42

Which analyst is the currently most reserved on LIFE (aTyr Pharma)?

Hartaj Singh with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?